Xxxx Name. Xxxxxx X. Xxxx Title: Chief Executive Officer With a copy to (which shall not constitute notice): Email: xxxxx@xxxxxxxxxxx.xxx Energy Focus, Inc. Xxxxx X. Xxxxxx Senior Vice President, General Counsel And Corporate Secretary 0000 Xxxxxx Xxxx, Xxxxx X Xxxxx, XX 00000 Email: xxxxxxx@xxxxxxxxxxx.xxx [PURCHASER SIGNATURE PAGES TO EFOI SECURITIES PURCHASE AGREEMENT]
Xxxx Name. The Advisor and its Affiliates have a proprietary interest in the name “Xxxx.” The Advisor hereby grants to the Company a non-transferable, non-assignable, non-exclusive royalty-free right and license to use the name “Xxxx” during the term of this Agreement. Accordingly, and in recognition of this right, if at any time the Company ceases to retain the Advisor or one of its Affiliates to perform advisory services for the Company, the Company shall, promptly, but in any case within 30 days (or such longer period of time as agreed to by the Advisor in its sole discretion), after receipt of a written request from the Advisor, cease to conduct business under or use the name “Xxxx” or any derivative thereof and the Company shall change its name and the names of any of its subsidiaries to a name that does not contain the name “Xxxx” or any other word or words that might, in the reasonable discretion of the Advisor, be susceptible of indication of some form of relationship between the Company and the Advisor or any its Affiliates. At such time, the Company will also make any changes to any trademarks, servicemarks or other marks necessary to remove any references to the word “Xxxx.” Consistent with the foregoing, it is specifically recognized that the Advisor or one or more of its Affiliates has in the past and may in the future organize, sponsor or otherwise permit to exist other investment vehicles (including vehicles for investment in real estate) and financial and service organizations having “Xxxx” as a part of their name, all without the need for any consent (and without the right to object thereto) by the Company. The Advisor shall have discretion over the Company’s use of the name “Xxxx” and the Company’s use of the “Xxxx” name will be in strict accordance with any quality standards and specifications that may be established by Advisor and communicated to Company from time to time.
Xxxx Name. A. Xxxxx Xxxxx ------------------------------- -------------------------------
Xxxx Name. Xxxxxx X. Xxxxx ----------------------------- -------------------- Title: CEO Title: President ----------------------------- -------------------- Date: 6/19/98 Date: 6/19/98 ----------------------------- -------------------- Address for Notices: Address for Notices: 0000 Xxxxxxxx #000 ----------------------------- --------------------------- Houston ----------------------------- --------------------------- XX 00000 ----------------------------- --------------------------- Phone: (000) 000 0000 Phone: -------------------- FAX: (000) 000 0000 FAX : -------------------- * OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. ATTACHMENT A (Muse U.S. Price List and Standard Terms & Conditions) U.S. COMMERCIAL PRICE LIST 1/1/98 PRODUCTS & PRODUCT SUPPORT SERVICES PRODUCT SOFTWARE DEVELOPMENT LICENSE ANNUAL SUPPORT AND INSTALLATION & LICENSE MAINTENANCE INTEGRATION ------------------------- --------------- -------------------- ----------------- SINGLE USER Foundation [ * ] [ * ] [ * ] Renaissance [ * ] [ * ] [ * ] SHARED ENVIRONMENT Continuum Foundation Renaissance with [ * ] [ * ] [ * ] Continuum Module APPLICATION RUN-TIME LICENSE Foundation [ * ] [ * ] Renaissance [ * ] [ * ] Continuum Foundation Renaissance Continuum [ * ] [ * ] APPLICATION PRODUCTS Solar System Development [ * ] [ * ] Run-Time Model [ * ] [ * ] StarDust Model [ * ] [ * ] Development [ * ] [ * ] Run-Time Model * OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. FEA Analyzer [ * ] [ * ] Development [ * ] [ * ] Run-Time ADD-ON MODULES Audio Software [ * ] [ * ] configuration dependent Voice Recognition [ * ] [ * ] configuration dependent Speech Synthesis [ * ] [ * ] configuration dependent Real Time Collision [ * ] [ * ] configuration dependent Detect TRAINING & CUSTOM SUPPORT SERVICES Training Class # PEOPLE ON-SITE OFF-SITE Site Administration (hardware) 5 2 days [ * ] [ * ] Site Administration (Software) 5 3 days [ * ] [ * ] Application Development Introductory 5 5 days [ * ] [ * ] Application Development Advanced 3 days [ * ] [ * ] Custom Classes Available Note: All International Orders require a [ * ] addendum to above listed prices: * OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. TRAINING & CUSTOM SUPPORT SERVICES Training Class # Persons Duration On-Site (?) Off-Site (?) Site Administration 5 2 Days [ * ] [ * ] (hardware) Site Administration 5 3 Days [ * ] [ * ] (Software) Application Development 5 5 Days [ * ] [ * ] Introductory Application Development 5 3 Days [...
Xxxx Name. Xxxxx X. Xxxxxx Title: Associate Center Director, Title: CEO Translational Research Appendix A LICENSED TECHNOLOGIES US Patent Application No. 63/002,292 titled “Delta Opioid Receptor Antagonists Reprogram Immunosuppressive Microenvironment to Boost Immunotherapy” filed March 30, 2020 (Moffitt ID No. 20MA012PR) LICENSED TECHNOLOGY IMPROVEMENTS Appendix B Development “PLAN” for the LICENSED TECHNOLOGY Guidelines For Development Plan ● This form is offered as an aid for the Due Diligence section of the License Agreement. The Innovation Office will accept any document that adheres to the guidelines as written in the License Agreement. ● Please complete this form electronically and return via email to Xxxxxxxxxx@Xxxxxxx.xxx. ● Text box fields will expand and rows can be added and deleted as needed; you are not limited to the space provided. Company Name and Address Primary Contact Name and Email Agreement Effective Date Date Submitted Company Fiscal Year End Description of research and development for the LICENSED TECHNOLOGY Description of preclinical and clinical testing for the LICENSED TECHNOLOGY Type of governmental approval required for LICENSED TECHNOLOGY Description of manufacturing process for LICENSED TECHNOLOGY Description of marketing strategy for the LICENSED TECHNOLOGY Expected sale or sublicense of the LICENSED TECHNOLOGY Appendix C Annual Progress Report · This form is offered as an aid for the Due Diligence section of the License Agreement. The Innovation Office will accept any document that adheres to the guidelines as written in the License Agreement. · Please fill this form out electronically and return via email to Innovation@ Xxxxxxx.xxx. ● Text box fields will expand and rows can be added and deleted as needed, you are not limited to the space provided. Licensee Name and Current Address: Name and Email of Primary Contact Reporting Period From: / / To: / / Date Submitted Effective Date of Original Agreement: Dates of Licensee Amendments:
Xxxx Name. Xxxxxx X. Xxxx Title: Manager, Contracts Regional Aircraft Agreed and accepted this 9th day of May, 2003 US Airways Group, Inc. /s/ Xxxxxxx X. XxXxxxxx Name: Xxxxxxx X. XxXxxxxx Title: Vice President - Finance and Treasurer Annex A to Letter Agreement No. 2 to MPA-505 Buyer Furnished Equipment
Xxxx Name. Xxxxx X. Xxxxxxxx ----------------------------- ----------------------------- Title: President ---------------------------- STATE OF OHIO ) ) SS: COUNTY OF XXXXXXXX ) The foregoing instrument was acknowledged before me this 23rd day of March, 2001, by Xxxxx X. Xxxxx, Vice President of Xx Xxxxx, Inc., an Ohio corporation, on behalf of the corporation. /s/ Xxxx X. Xxxxxxx ------------------------------- Notary Public STATE OF OHIO ) ) SS: COUNTY OF XXXXXXXX ) The foregoing instrument was acknowledged before me this 21st day of March, 2001 by Xxxxx X. Xxxxxxxx, the President of Cintech Solutions, Inc., an Ohio corporation, on behalf of the corporation. /s/ Xxxxx X.Xxxxxx ------------------------------- Notary Public
Xxxx Name. Xxxxxxx Xxxxxxxxx ----------------------------- ---------------------------- Title: Head of Strategic Business Title: President & C.O.O ---------------------------- --------------------------- Unit Therapeutics ---------------------------- Date: 22nd April 1999 Date: May 11, 1999 ----------------------------- ----------------------------
Xxxx Name. Xxxxxxx X. Xxxxxxxx -------------------------- ----------------------------------- Its: Owner Its: President -------------------------- -----------------------------------
Xxxx Name. Xxxxxxx X. Xxxxxxx ---------------------------- --------------------------------- Title President Title: Manager, Licensing ---------------------------- Office of Technology Transfer Date June 1, 1994 Date 6/20/94 ---------------------------- --------------------------------- IMAGENETICS INCORPORATED By /s/ X.X. Xxxxxx ------------------------------
